Prosecution Insights
Prosecution Insights
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (44%) |
| §112 only | 2 (22%) |
| No statute on record | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAPCIAK, SHARON M | 1 | 49.6% | +22.3% |
| JOHANSEN, PETER N. | 1 | 60.0% | +23.8% |
| DUNN, LINDSAY MICHELLE | 1 | 100.0% | +0.0% |
| BURKHART, MICHAEL D | 1 | 62.4% | +10.9% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 50.0% | +46.7% |
| GODDARD, LAURA B | 1 | 50.7% | +14.6% |
| TICHY, JENNIFER M.H. | 1 | 65.2% | +33.8% |
| WU, JULIE ZHEN QIN | 1 | 61.8% | +52.2% |
| RIGA, MICHAEL ANGELO | 1 | 51.8% | +63.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18368647 | METHODS OF PERSONALIZED PRECONDITIONING FOR CELL THERAPY | DUNN, LINDSAY MICHELLE | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17817735 | CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOF | GODDARD, LAURA B | 8d overdue |
| 17514742 | NON-INVASIVE METHODS FOR SELECTIVELY ENRICHING PLURIPOTENT CELLS | TICHY, JENNIFER M.H. | 4d overdue |
| 16990185 | NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF | RIGA, MICHAEL ANGELO | 4d overdue |
| 18606866 | INTESTINAL MICROBIOTA AND GVHD | PAPCIAK, SHARON M | 6d |
| 18506518 | ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF | JOHANSEN, PETER N. | 28d |
| 17400689 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | WU, JULIE ZHEN QIN | 33d |
| 17890694 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL | BUCHANAN, BAILEY CHEYENNE | 34d |
| 18118072 | METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE | BURKHART, MICHAEL D | 41d |
| Art Unit | Apps |
|---|---|
| 1644 | 2 |
| 1657 | 1 |
| 1638 | 1 |
| 1682 | 1 |
| 1642 | 1 |
| 1653 | 1 |
| 1643 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18606866 | INTESTINAL MICROBIOTA AND GVHD | PAPCIAK, SHARON M | 1657 | §103 | Final Rejection | 6d | Pending | Mar 15, 2024 |
| 18506518 | ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF | JOHANSEN, PETER N. | 1644 | §103 | Non-Final OA | 28d | Pending | Nov 10, 2023 |
| 18368647 | METHODS OF PERSONALIZED PRECONDITIONING FOR CELL THERAPY | DUNN, LINDSAY MICHELLE | 1644 | §103 | Non-Final OA | 26d | Pending | Sep 15, 2023 |
| 18118072 | METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE | BURKHART, MICHAEL D | 1638 | §112 | Non-Final OA | 41d | Pending | Mar 06, 2023 |
| 17890694 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL | BUCHANAN, BAILEY CHEYENNE | 1682 | Other | Non-Final OA | 34d | Pending | Aug 18, 2022 |
| 17817735 | CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOF | GODDARD, LAURA B | 1642 | Other | Non-Final OA | 8d overdue | Pending | Aug 05, 2022 |
| 17514742 | NON-INVASIVE METHODS FOR SELECTIVELY ENRICHING PLURIPOTENT CELLS | TICHY, JENNIFER M.H. | 1653 | Other | Non-Final OA | 4d overdue | Pending | Oct 29, 2021 |
| 17400689 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | WU, JULIE ZHEN QIN | 1643 | §103 | Final Rejection | 33d | Pending | Aug 12, 2021 |
| 16990185 | NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF | RIGA, MICHAEL ANGELO | 1634 | §112 | Non-Final OA | 4d overdue | Pending | Aug 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial